Trademark Overview
On Thursday, November 14, 2024, a trademark application was filed for XENLYM with the United States Patent and Trademark Office. The USPTO has given the XENLYM trademark a serial number of 79413400. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 26, 2024. This trademark is owned by Boehringer Ingelheim Vetmedica GmbH. The XENLYM trademark is filed in the Pharmaceutical Products category with the following description:
Veterinary preparations, for the prevention and the treatment of metabolic diseases disorders; veterinary preparations for the prevention and the treatment of cardiovascular diseases; veterinary preparations for the prevention and the treatment of neurological diseases and disorders; veterinary preparations for the prevention and the treatment of musculoskeletal diseases and disorders; veterinary preparations for the prevention and treatment of tendon and muscle damages and injuries; veterinary preparations against bacterial infections, namely, antibiotics, anti-infectives; veterinary preparations for the prevention and the treatment of respiratory diseases; veterinary preparations for the treatment of inflammatory diseases; veterinary preparations for udder care; vaccines for veterinary use; sedatives for veterinary use; stem cells for veterinary use; surgical implants comprising living tissue and grown from stem cells for veterinary use; dietary and nutritional supplements for animal...
